Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.51 |
| ▸ | CA1 | P00915 | 3/20 | 0.51 |
| ▸ | CA2 | P00918 | 3/20 | 0.51 |
| ▸ | CA7 | P43166 | 3/20 | 0.51 |
| ▸ | CA9 | Q16790 | 3/20 | 0.51 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | TDP2 | O95551 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL822588 | 0.95 | CA12 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10044166 | 0.92 | CA12 (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9999677 | 0.89 | CA12 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15430908 | 0.84 | CA12 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16330271 | 0.84 | CA12 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13429588 | 0.83 | CA12 (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL31083917 | 0.81 | CA12 (0.70) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2313707 | 0.81 | CA12 (0.70) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13429819 | 0.81 | CA12 (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL812044 | 0.80 | PTPN11 (0.42) | LMNAKMT2AALDH1A1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3235891-A1 | COMPOSITION AND LIGHT-EMITTING ELEMENT USING SAME | Sumitomo Chemical Company, Ltd. (JP) | 2017-10-25 | — | — | EP | disclosed |
| EP-3171673-A1 | METHOD FOR MANUFACTURING LIGHT EMITTING ELEMENT | Sumitomo Chemical Company Limited (JP) | 2017-05-24 | — | — | EP | disclosed |
| US-8052894-B2 | Salicylate substituted conjugated polymers and devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-08 | — | — | US | disclosed |
| US-20090001324-A1 | Salicylate Substituted Conjugated Polymers and Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090001324-A1 | Salicylate Substituted Conjugated Polymers and Devices | TLR9, TLR5, TLR1 | CA12 2214/4885CA1 2976/4885CA2 3233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.